• Oncology Pharmacogenetics (PGx) Gene Variation Panel
  • Tuberculosis Cell Mediated Immunity Antigen Response (T-SPOTĀ®. TB) Test
  • Ehrlichia chaffeensis Antibody, IgM
  • Thyroglobulin, Serum
  • Epidermal Nerve Fiber Density (ENFD)
  • Vitamin K Epoxide Reductase Complex, Subunit 1 (VKORC1) Genotyping
  • Potassium, Serum
  • Hereditary Angioedema Diagnostic Panel
  • Maprotiline, Urine
  • Immunoglobulin G (IgG)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Inhibitor Screen (1:1 Mix), Mixing Studies
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Inhibitor Screen (1:1 Mix), Mixing Studies
Medical Test

Clinical Utility
Access to Inhibitor Screen (1:1 Mix), Mixing Studies is restricted.